125 related articles for article (PubMed ID: 23757116)
41. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
42. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2009 Aug; 71(2):291-7. PubMed ID: 19067727
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous medullary and papillary thyroid cancer: a novel entity?
Machens A; Dralle H
Ann Surg Oncol; 2012 Jan; 19(1):37-44. PubMed ID: 21626080
[TBL] [Abstract][Full Text] [Related]
44. Secondary hyperparathyroidism and nonmedullary thyroid cancer.
Nash E; Eldar S; Shajrawi I; Abrahamson J; Schein M
Isr J Med Sci; 1995; 31(2-3):186-8. PubMed ID: 7744592
[TBL] [Abstract][Full Text] [Related]
45. Medullary and mixed medullary-papillary carcinoma of the thyroid gland.
Macák J; Vaverková H; Dushová M; Perglerová I
Pathologica; 1997 Jun; 89(3):317-22. PubMed ID: 9270266
[TBL] [Abstract][Full Text] [Related]
46. [Toxic nodular goitre associated with papillary thyroid carcinoma and primary hyperparathyroidism].
Turki ZM; Hajri H; Zrig N; Kourda N; Ferjaoui M; Ben Slama C
Rev Laryngol Otol Rhinol (Bord); 2006; 127(4):239-42. PubMed ID: 17315788
[TBL] [Abstract][Full Text] [Related]
47. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
48. Differences in Clinicopathological Characteristics of Papillary Thyroid Carcinoma between Symptomatic and Asymptomatic Patients with Primary Hyperparathyroidism.
Liu Y; Guo S; Sang S; Liu J; Qi L; Lv B; Zhang X
Int J Endocrinol; 2021; 2021():9917694. PubMed ID: 34158812
[TBL] [Abstract][Full Text] [Related]
49. Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.
Crezee T; Tesselaar MH; Nagarajah J; Corver WE; Morreau J; Pritchard C; Kimura S; Kuiper JG; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
Cell Oncol (Dordr); 2021 Jun; 44(3):611-625. PubMed ID: 33534128
[TBL] [Abstract][Full Text] [Related]
50. Genetic predisposition for nonmedullary thyroid cancer.
Nagy R; Ringel MD
Horm Cancer; 2015 Feb; 6(1):13-20. PubMed ID: 25338077
[TBL] [Abstract][Full Text] [Related]
51. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.
Pal T; Vogl FD; Chappuis PO; Tsang R; Brierley J; Renard H; Sanders K; Kantemiroff T; Bagha S; Goldgar DE; Narod SA; Foulkes WD
J Clin Endocrinol Metab; 2001 Nov; 86(11):5307-12. PubMed ID: 11701697
[TBL] [Abstract][Full Text] [Related]
52. An unusual presentation of primary hyperparathyroidism: multiple brown tumors and coexisting thyroid carcinoma.
Basaran Y; Ince S; Alagoz E; Meric C; Taslipinar A
Rev Esp Med Nucl Imagen Mol; 2016; 35(5):321-4. PubMed ID: 27036887
[TBL] [Abstract][Full Text] [Related]
53. Coexistence of a large functioning parathyroid cyst with papillary thyroid carcinoma: A case report and review of the literature.
Anagnostis P; Panagiotou A; Rafailidis S; Kita M
Case Rep Womens Health; 2019 Jan; 21():e00091. PubMed ID: 30591913
[TBL] [Abstract][Full Text] [Related]
54. Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.
Capezzone M; Sagnella A; Cantara S; Fralassi N; Maino F; Forleo R; Brilli L; Pilli T; Cartocci A; Castagna MG
Front Endocrinol (Lausanne); 2022; 13():845954. PubMed ID: 35311228
[TBL] [Abstract][Full Text] [Related]
55. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
[TBL] [Abstract][Full Text] [Related]
56. [Primary hyperparathyroidism in patient with thyroid papillary cancer--case report].
Rajewska J; Łacka K; Stawny B; Majewski P
Pol Merkur Lekarski; 2010 Dec; 29(174):373-6. PubMed ID: 21298988
[TBL] [Abstract][Full Text] [Related]
57. Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
Yu Q; Liu K; Ma D; Xie C; Wu Y; Dai W; Jiang H
Biomed Res Int; 2019; 2019():2150159. PubMed ID: 31355250
[TBL] [Abstract][Full Text] [Related]
58. [Mixed medullary-papillary thyroid carcinoma: report of a case].
Gao ZB; Wang ZP; Zhao Y; Yu XR
Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):716-7. PubMed ID: 19094497
[No Abstract] [Full Text] [Related]
59. Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review.
Cinamon U; Levy D; Marom T
Int Arch Otorhinolaryngol; 2015 Jan; 19(1):42-5. PubMed ID: 25992150
[TBL] [Abstract][Full Text] [Related]
60. Incidental Finding of Papillary Thyroid Carcinoma in the Patients with Primary Hyperparathyroidism.
Yazici P; Mihmanli M; Bozdag E; Aygun N; Uludag M
Eurasian J Med; 2015 Oct; 47(3):194-8. PubMed ID: 26644769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
